| Literature DB >> 30766463 |
Anna M Piotrowska1, Monika Bigosińska2, Halina Potok3, Urszula Cisoń-Apanasewicz3, Olga Czerwińska-Ledwig1, Łukasz M Tota4, Roxana Zuziak1, Tomasz Pałka4, Wanda Pilch1.
Abstract
INTRODUCTION: Vibration therapy interventions are an attractive alternative for people with contraindications to physical activity or manifesting kinesiophobia; they constitute an equivalent to physical activity.Entities:
Keywords: LDL cholesterol; atherogenic indices; hypercholesterolemia; therapeutic use of vibration
Year: 2018 PMID: 30766463 PMCID: PMC6372848 DOI: 10.5114/pm.2018.81739
Source DB: PubMed Journal: Prz Menopauzalny ISSN: 1643-8876
Fig. 1Patient flow diagram
General characteristics of the studied women before and after the series of vibrotherapy treatments
| Control group | Study group | ||
|---|---|---|---|
| before | 71.26 ±8.89 | 72.32 ±6.52 | 0.363 |
| after | 70.70 ±8.22 | 71.85 ±6.32 | |
| | 0.234 | 0.236 | |
| 158.11 ±6.64 | 160 ±7.25 | 0.257 | |
| before | 28.46 ±2.60 | 28.20 ±2.74 | 0.408 |
| after | 28.25 ±2.37 | 28.14 ±2.74 | |
| | 0.390 | 0.306 | |
| before | 29715 ±5872 | 30285 ±3550 | 0.377 |
| after | 29407 ±5863 | 30054 ±3903 | 0.332 |
| | 0.386 | 0.166 | |
| before | 42.77 ±4.26 | 43.17 ±2.94 | 0.399 |
| after | 42.62 ±5.02 | 43.01 ±3.33 | |
| | 0.206 | 0.450 | |
| before | 39372 ±3984 | 39890 ±3951 | 0.375 |
| after | 39201 ±4171 | 39682 ±3615 | |
| | 0.207 | 0.274 | |
| before | 2090 ±379 | 2128 ±242 | 0.375 |
| after | 2084 ±368 | 2113 ±259 | |
| | 0.332 | 0.263 | |
The results are presented as mean values along with standard deviations. %fat – fat percentage; Fat – fat mass; LBM – lean body mass; BMC – bone mineral content; BMI – body mass index. p (control group vs. study group) t-test for independent means, p* (before vs. after) t-test for dependent means.
The average energy and basic nutrients content in the diet of the studied women
| Control group | Study group | ||
|---|---|---|---|
| 1496 ±454 | 1643 ±539 | 0.497 | |
| 75 ±27 | 74 ±31 | 0.487 | |
| 231 ±63 | 240 ±93 | 0.403 | |
| 22 ±6 | 23 ±10 | 0.359 | |
| 54 ±17 | 50 ±16 | 0.280 | |
| 20 ±4 | 18 ±7 | 0.309 | |
| 21 ±8 | 18 ±6 | 0.164 | |
| 8 ±5 | 8 ±4 | 0.466 | |
| 252 ±79 | 297 ±103 | 0.163 | |
| 2452 ±1045 | 1850 ±957 | 0.095 |
The results are presented as mean values along with standard deviations. SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polysaturated fatty acids. p (control group vs. study group) t-test for independent means.
Changes in the lipid profile in studied women
| Control group | Study group | ||
|---|---|---|---|
| before | 6.28 ±0.66 | 6.16 ±0.77 | 0.346 |
| After | 6.13 ±0.64 | 5.79 ±0.79 | 0.064 |
| one week after | 6.13 ±0.61 | 5.97 ±0.65 | 0.276 |
| | 0.854 | ||
| before | 1.85 ±0.40 | 1.69 ±0.26 | 0.102 |
| after | 1.84 ±0.31 | 1.72 ±0.27 | 0.164 |
| one week after | 1.75 ±0.27 | 1.72 ±0.27 | 0.377 |
| | 0.780 | 0.921 | |
| before | 3.80 ±0.67 | 3.76 ±0.69 | 0.440 |
| after | 3.68 ±0.54 | 3.38 ±0.68 | |
| one week after | 3.77 ±0.64 | 3.60 ±0.57 | 0.237 |
| | 0.907 | ||
| before | 1.25 ±0.46 | 1.34 ±0.47 | 0.311 |
| after | 1.29 ±0.42 | 1.22 ±0.44 | 0.346 |
| one week after | 1.17 ±0.22 | 1.28 ±0.47 | 0.264 |
| | 0.831 | 0.740 | |
The results are presented as mean values along with standard deviations. TG – total cholesterol; HDL – high-density lipoprotein; LDL – low-density lipoprotein; TG – triglycerides. p (control group vs. study group) t-test for independent means; p* (intra-group changes) one-way ANOVA for repeated measurements. Statistically significant results are in bold (p < 0.05).
Indicators of fat distribution in the study and control group
| Control group | Study group | ||
|---|---|---|---|
| before | 91.37 ±6.36 | 92.78 ±8.04 | 0.663 |
| after | 90.00 ±8.03 | 91.89 ±7.28 | 0.554 |
| | 0.258 | 0.190 | |
| before | 104.00 ±6.59 | 107.36 ±5.87 | 0.200 |
| after | 104.00 ±6.69 | 106.42 ±5.63 | 0.343 |
| | 1.000 | ||
| before | 1.07 ±0.09 | 1.09 ±0.11 | 0.654 |
| after | 1.09 ±0.09 | 1.09 ±0.10 | 0.942 |
| | 0.492 | 0.816 | |
| before | 0.87 ±0.02 | 0.86 ±0.04 | 0.406 |
| after | 0.86 ±0.04 | 0.86 ±0.04 | 0.943 |
| | 0.273 | 0.972 | |
The results are presented as mean values along with standard deviations. WC – waist circumference; HC – hip circumference; A/G ratio android-to-gynoid ratio (android fat mass/gynoid fat mass); WHR – waist-hip ratio. p (control group vs. study group) t-test for independent means, p* (before vs. after) t-test for dependent means; statistically significant results are in bold (p < 0.05).
Atherogenic indexes of women from the study and control groups
| Control group | Study group | ||||
|---|---|---|---|---|---|
| before | 3.64 ±0.67 | 3.69 ±0.59 | 0.824 | ||
| after | 3.48 ±0.57 | 0.166 | 3.49 ±0.59 | 0.068 | 0.961 |
| one week after | 3.66 ±0.67 | 0.183 | 3.55 ±0.63 | 0.611 | 0.670 |
| before | 2.24 ±0.49 | 2.25 ±0.40 | 0.952 | ||
| after | 2.11 ±0.45 | 0.155 | 2.11 ±0.48 | 0.086 | 0.974 |
| one week after | 2.27 ±0.52 | 0.138 | 2.13 ±0.44 | 0.802 | 0.506 |
| before | 0.243 ±0.26 | 0.284 ±0.23 | 1.000 | ||
| after | 0.239 ±0.18 | 0.723 | 0.223 ±0.22 | 0.852 | |
| one week after | 0.252 ±0.19 | 0.723 | 0.251 ±0.23 | 0.643 | 0.651 |
| before | 2.64 ±0.67 | 2.70 ±0.59 | 0.824 | ||
| after | 2.48 ±0.57 | 0.166 | 2.50 ±0.59 | 0.068 | 0.962 |
| one week after | 2.66 ±0.67 | 0.183 | 2.55 ±0.63 | 0.611 | 0.670 |
The results are presented as mean values along with standard deviations. p* (intra-group changes) CI – Castelli Risk Index I; CII – Castelli Risk Index II; AC – atherogenic coefficient – t-test; AIP – Atherogenic Index of Plasma – Mann-Whitney U test, p (control group vs. study group) CI, CII t-test, AIP Wilcoxon signed-rank test; statistically significant results are in bold (p < 0.05).
Effect of vibrotherapy on atherogenic indexes
| Reference range | Control group (percent of women with abnormalities) | Study group (percent of women with abnormalities) | ||
|---|---|---|---|---|
| CI | < 4.0 | before | 12.5 | 31.5 |
| after | 12.5 | 21 | ||
| CII | < 3 | before | 0 | 0 |
| after | 0 | 0 | ||
| AIP | < 0.24 | before | 62.5 | 47.3 |
| after | 62.5 | 31.5 | ||
| AC | < 3 | before | 12.5 | 31.5 |
| after | 12.5 | 21 | ||
The results are presented as percent values. CI – Castelli Risk Index I, CII – Castelli Risk Index II, AIP – Atherogenic Index of Plasma, AC – atherogenic coefficient